Renal arteriosclerosis is common in patients with lupus nephritis and occurs two decades earlier than it does in people without the condition, say investigators in a study that examined the prevalence of renal arteriosclerosis in patients with lupus nephritis compared with healthy controls.1 The finding suggests that renal arteriosclerosis could be used as a biomarker…
At this Practice Innovation Summit session, experts discussed the challenges that come with surviving as an independent rheumatology practice in the current health environment.
Dr. Heidi Prather detailed how social prescription may aid patients with chronic diseases and the research supporting this approach to care in her keynote speech during ACR Convergence 2025.
At this ACR Convergence session, experts discussed the peripheral nervous system involvement with Sjögren’s disease that can have several manifestations.
At this ACR Convergence session, experts provided an overview of the new ACR guideline for juvenile idiopathic arthritis.
Discover the latest ILD management strategies for RA, SSc & myositis, plus expert guidance on pregnancy & defining progressive pulmonary fibrosis.
At the inaugural Practice Innovation Summit, two experts offered advice on negotiating insurance contracts.
At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.
Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.
Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.